Physician profile
Ken H Wolfe
NPI 1528051745
$1,094.43
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $863 · 2020: $232.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $222.01 | 2019-2020 | |
| Glaxosmithkline, LLC. | $109.02 | 2019-2020 | |
| Abbvie INC. | $87.04 | 2019 | |
| Pfizer INC. | $65.51 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $65.24 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $63.26 | 2019 | |
| Genzyme Corporation | $52.29 | 2019 | |
| Hikma Pharmaceuticals USA | $47.99 | 2019-2020 | |
| Celgene Corporation | $47.36 | 2019 | |
| Genentech USA, INC. | $41.86 | 2019-2020 | |
| Janssen Biotech, INC. | $38.74 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.70 | 2020 | |
| Mallinckrodt Enterprises LLC | $33.35 | 2019 | |
| Mallinckrodt Hospital Products INC. | $30.24 | 2020 | |
| Ucb, INC. | $26.78 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medexus Pharma, INC. | $26.20 | 2019 | |
| Sanofi-Aventis U.S. LLC | $20.10 | 2019 | |
| Radius Health, INC. | $20.01 | 2019 | |
| Sobi, INC | $19.35 | 2019 | |
| Lilly USA, LLC | $17.67 | 2019 | |
| Collegium Pharmaceutical, INC. | $15.82 | 2019 | |
| Sebela Pharmaceuticals INC. | $10.89 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ken Wolfe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.